559 research outputs found
Arun Shourie and his Christian critic
Critique by Fr. Augustine Kanjamala on Arun Shourie's Missionaries in India and response to it by the author
R16. Formulation and Evaluation of Doxorubicin HCl Nanoliposomes by Ethanol Injection Method
Corresponding author (Pharmaceutics and Drug delivery): Arun Kumar Kotha, [email protected]://egrove.olemiss.edu/pharm_annual_posters/1015/thumbnail.jp
Radiation dose to contra lateral breast during treatment of breast malignancy by radiotherapy
Aims: External beam radiotherapy is being used regularly to treat the
breast malignancy postoperatively. The contribution of collimator
leakage and scatter radiation dose to contralateral breast is of
concern because of high radio sensitivity of breast tissue for
carcinogenesis. This becomes more important when the treated cancer
breast patient is younger than 45 years and therefore the contralateral
breast must be treated as organ at risk. Quantification of
contralateral dose during primary breast irradiation is helpful to
estimate the risk of radiation induced secondary breast malignancy.
Materials and Methods: In present study contralateral breast dose was
measured in 30 cancer breast patients undergoing external beam therapy
by Co-60 teletherapy machine. Postoperative radiotherapy was delivered
by medial and lateral tangential fields on alternate days in addition
to supraclavicle field daily with 200 cGy/F to a total dose of 5000 cGy
in 25 fractions. CaSO4: Dy themoluminescence dosimeter discs were
employed for these measurements. Three TLD discs were put on the
surface of skin of contra lateral breast, one at the level of nipple
and two at 3 cms away from nipple on both side along the midline for
each field. At the end treatment of each filed, TLD discs were removed
and measured for dose after 24h on Thelmador - 6000 TLD reader.
Results: The dose at the contra lateral breast nipple was to be 152.5
to 254.75 cGy for total primary breast dose of 5000 cGy in 25 equal
fractions which amounted to 3.05-6.05% of total dose to diseased
breast. Further it was observed that the maximum contribution of
contralateral breast dose was due to medical tangential half blocked
field. Conclusion: CaSO4; Dy thermoluminescence dosimetry is quite
easy, accurate and convenient method to measure the contra lateral
breast dose
The International Organization for Medical Physics – a driving force for the global development of medical physics
The International Organization for Medical Physics (IOMP) is the world’s largest professional organization in the field of medical physics and has official non-governmental organization status with the World Health Organization (WHO) and the International Atomic Energy Agency (IAEA). IOMP is charged with a mission to advance medical physics practice worldwide by disseminating scientific and technical information, fostering the educational and professional development of medical physics and promoting the highest quality medical services for patients. IOMP’s activities are directed towards the promotion of medical physics globally, improving patient care, and contributing to the benefit of healthcare to the society. Major organizational activities include but are not limited to scientific events, international collaborations, dissemination of information, education, training, and research. For nearly 60 years of existence, IOMP turned into a key factor not only in the field of medical physics, but also healthcare, and other related disciplines. IOMP is looking forward to future perspectives in international collaboration and enhancement of the professional skills, all directed towards enhancing patient benefit
R14. Amikacin extended release nanoliposomes using the ethanol injection method: development and characterization
Corresponding author (Pharmaceutics and Drug delivery): Rama Kashikar, [email protected]://egrove.olemiss.edu/pharm_annual_posters/1013/thumbnail.jp
Radiation dose to contra lateral breast during treatment of breast malignancy by radiotherapy
Aims: External beam radiotherapy is being used regularly to treat the
breast malignancy postoperatively. The contribution of collimator
leakage and scatter radiation dose to contralateral breast is of
concern because of high radio sensitivity of breast tissue for
carcinogenesis. This becomes more important when the treated cancer
breast patient is younger than 45 years and therefore the contralateral
breast must be treated as organ at risk. Quantification of
contralateral dose during primary breast irradiation is helpful to
estimate the risk of radiation induced secondary breast malignancy.
Materials and Methods: In present study contralateral breast dose was
measured in 30 cancer breast patients undergoing external beam therapy
by Co-60 teletherapy machine. Postoperative radiotherapy was delivered
by medial and lateral tangential fields on alternate days in addition
to supraclavicle field daily with 200 cGy/F to a total dose of 5000 cGy
in 25 fractions. CaSO4: Dy themoluminescence dosimeter discs were
employed for these measurements. Three TLD discs were put on the
surface of skin of contra lateral breast, one at the level of nipple
and two at 3 cms away from nipple on both side along the midline for
each field. At the end treatment of each filed, TLD discs were removed
and measured for dose after 24h on Thelmador - 6000 TLD reader.
Results: The dose at the contra lateral breast nipple was to be 152.5
to 254.75 cGy for total primary breast dose of 5000 cGy in 25 equal
fractions which amounted to 3.05-6.05% of total dose to diseased
breast. Further it was observed that the maximum contribution of
contralateral breast dose was due to medical tangential half blocked
field. Conclusion: CaSO4; Dy thermoluminescence dosimetry is quite
easy, accurate and convenient method to measure the contra lateral
breast dose
Radiation dose to contra lateral breast during treatment of breast malignancy by radiotherapy
Understanding the value-chain of counterfeit products: A multimethod investigation
The student, - Sreekumar Arun, accepted the attached license on 2021-04-13 at 23:09.The student, - Sreekumar Arun, submitted this Dissertation for approval on 2021-04-13 at 23:23.This Dissertation was approved for publication on 2021-04-15 at 11:53.DSpace SAF Submission Ingestion Package generated from Vireo submission #16317 on 2021-09-16 at 17:03:02Made available in DSpace on 2021-09-17T02:34:25Z (GMT). No. of bitstreams: 2
SREEKUMARARUN-DISSERTATION-2021.pdf: 1165555 bytes, checksum: 5224c2afec936d334243407f8cdc4a58 (MD5)
LICENSE.txt: 4213 bytes, checksum: 6a931b7df048f222f1bf46543b830705 (MD5)
Previous issue date: 2021-04-15Embargo set by: Seth Robbins for item 118507
Lift date: 2023-09-17T02:34:57Z
Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD systemAuthor requested U of Illinois access only (OA after 2yrs) in Vireo ETD systemU of I OnlyThe context of this dissertation is the market for counterfeit products, which accounts for more than one trillion US dollars of trade globally every year. Entrepreneurs who manufacture and market these products are clandestine and operate in the black market. Drawing from this context, this dissertation seeks to advance knowledge on how entrepreneurs strategically use ambiguity in marketing communications, and in relationships with other firms. The first essay examines how and why equivocation is used as a persuasive strategy by sellers of counterfeit products. This essay develops a framework that can help qualitatively and quantitatively identify equivocation rhetoric in firm-generated text. The second essay examines how relationships between firms are managed when one of the firms employs ambiguity as a protection strategy. Specifically, the essay sheds light on how manufacturers and retailers of counterfeit products succeed in maintaining ambiguity, and in managing relationship tension arising from ambiguity. Put together, the essays present an investigation of how counterfeit manufacturers and retailers conduct their marketing functions despite being clandestine and illegal.Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2023-05-0
- …
